{
    "clinical_study": {
        "@rank": "3301", 
        "arm_group": {
            "arm_group_label": "Neurofibromatosis type 1 children"
        }, 
        "brief_summary": {
            "textblock": "The goal of this project is to get more insight into the (neuro)ophthalmological\n      characteristics of children with neurofibromatosis type 1. This way investigators would like\n      to update the current guidelines for follow up and treatment of optic pathway gliomas.\n      Clinical findings will be compared with the results of Optical coherence tomography (OCT)\n      and MRI (magnetic resonance imaging)."
        }, 
        "brief_title": "Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.", 
        "condition": "Neurofibromatosis Type 1", 
        "condition_browse": {
            "mesh_term": [
                "Glioma", 
                "Neurofibromatoses", 
                "Neurofibromatosis 1", 
                "Osteitis Fibrosa Cystica"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  neurofibromatosis type 1\n\n        Exclusion Criteria:\n\n          -  no neurofibromatosis type 1"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Children with neurofibromatosis type 1 with and without optic pathway glioma"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02078401", 
            "org_study_id": "S56406"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Optic pathway glioma", 
            "Ophthalmological screening"
        ], 
        "lastchanged_date": "March 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "zip": "3000"
                }, 
                "name": "University Hospitals Leuven"
            }, 
            "investigator": {
                "last_name": "Catherine Cassiman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "1", 
        "official_title": "Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.", 
        "overall_contact": {
            "email": "catherine.cassiman@uzleuven.be", 
            "last_name": "Catherine Cassiman, MD", 
            "phone": "00321632660"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Visual acuity", 
                "safety_issue": "No", 
                "time_frame": "childhood (0 to 18y)"
            }, 
            {
                "measure": "Presence of optic pathway glioma", 
                "safety_issue": "No", 
                "time_frame": "childhood (0 to18y)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02078401"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universitaire Ziekenhuizen Leuven", 
            "investigator_full_name": "Dr. Catherine Cassiman", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}